Tag: LY3127804

Lilly to test Olumiant, LY3127804 against COVID-19

by Selina McKee | Apr 14, 2020 | News | 0

The RA drug Olumiant will be assessed in patients hospitalised with the virus

Read More

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN

E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999